F/m Emerald Life Sciences Innovation ETF (LFSC) is an ETF managed by Independent / Boutique. Its largest position is Cogent Biosciences, Inc. (COGT), representing 9.05% of fund assets.
F/m Emerald Life Sciences Innovation ETF Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- LFSC
- Type:
- ETF
- Manager:
- Independent / Boutique
- Total Assets:
- —
- Report Date:
- Feb 28, 2026
- Filing Date:
- Apr 28, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
Cogent Biosciences, Inc.
|
9.05% | $8,653,954.05 | 222,753 |
|
-
LivaNova PLC
|
7.36% | $7,038,537.60 | 99,696 |
|
-
TransMedics Group, Inc.
|
5.26% | $5,031,661.14 | 34,639 |
|
-
Mirum Pharmaceuticals, Inc.
|
4.84% | $4,628,158.92 | 50,148 |
|
-
Travere Therapeutics, Inc.
|
4.63% | $4,425,095.97 | 148,543 |
|
-
Spyre Therapeutics, Inc.
|
4.41% | $4,213,947.76 | 97,976 |
|
-
UNITED THERAPEUTICS Corp
|
4.35% | $4,162,214.00 | 8,260 |
|
-
Guardant Health, Inc.
|
4.32% | $4,134,135.30 | 44,027 |
|
-
Wave Life Sciences, Inc.
|
4.21% | $4,024,836.69 | 288,933 |
|
-
Savara Inc
|
4.04% | $3,860,385.20 | 641,260 |
|
-
KALVISTA PHARMACEUTICALS INC
|
3.81% | $3,640,061.48 | 223,591 |
|
-
NEKTAR THERAPEUTICS
|
3.61% | $3,456,863.72 | 50,114 |
|
-
ICU MEDICAL INC/DE
|
3.03% | $2,895,352.24 | 19,228 |
|
-
Trevi Therapeutics, Inc.
|
2.84% | $2,719,202.32 | 228,121 |
|
-
BridgeBio Pharma, Inc.
|
2.56% | $2,450,984.64 | 36,868 |
|
-
ACADIA PHARMACEUTICALS INC
|
2.44% | $2,334,477.12 | 95,052 |
|
-
Integer Holdings Corp
|
2.18% | $2,088,467.92 | 24,094 |
|
-
Axsome Therapeutics, Inc.
|
2.15% | $2,054,525.04 | 12,536 |
|
-
COLLEGIUM PHARMACEUTICAL, INC
|
2.06% | $1,969,990.92 | 47,276 |
|
-
MADRIGAL PHARMACEUTICALS, INC.
|
1.76% | $1,682,208.00 | 3,894 |
|
-
Ceribell, Inc.
|
1.70% | $1,624,868.77 | 87,031 |
|
-
GLOBUS MEDICAL INC
|
1.60% | $1,528,982.82 | 16,017 |
|
-
CORCEPT THERAPEUTICS INC
|
1.52% | $1,449,241.50 | 40,595 |
|
-
Waystar Holding Corp.
|
1.46% | $1,393,641.45 | 54,333 |
|
-
Lumexa Imaging Holdings, Inc.
|
1.38% | $1,322,853.56 | 93,554 |
|
-
CYTOKINETICS INC
|
1.38% | $1,321,303.92 | 21,236 |
|
-
BillionToOne, Inc.
|
1.33% | $1,271,428.81 | 16,657 |
|
-
Xeris Biopharma Holdings, Inc.
|
1.31% | $1,251,123.84 | 204,432 |
|
-
Alphatec Holdings, Inc.
|
1.09% | $1,038,225.36 | 76,228 |
|
-
RadNet, Inc.
|
1.07% | $1,024,810.80 | 14,680 |
|
-
Hinge Health, Inc.
|
1.07% | $1,019,697.72 | 23,847 |
|
-
SOLENO THERAPEUTICS INC
|
1.06% | $1,016,796.75 | 26,025 |
|
-
Corvus Pharmaceuticals, Inc.
|
1.00% | $958,266.54 | 52,479 |
|
-
INSMED Inc
|
0.93% | $890,305.46 | 5,962 |
|
-
Aveanna Healthcare Holdings, Inc.
|
0.80% | $766,838.40 | 104,190 |
|
-
Korro Bio, Inc.
|
0.79% | $751,028.95 | 61,915 |
|
-
F/M US TREASURY 6 MONTH BILL E
|
0.66% | $633,256.20 | 12,655 |
|
-
F/M ULTRASHORT TREASURY INFLAT
|
0.56% | $533,320.00 | 10,720 |
|
-
NEOGENOMICS INC
|
0.44% | $417,077.07 | 42,429 |
|
-
U.S. BANK MONEY MARKET DEPOSIT ACCOUNT
|
0.00% | $271.35 | 271 |
Advertisement (320x50)